StockNews.com Begins Coverage on Blueprint Medicines (NASDAQ:BPMC)

StockNews.com initiated coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Get Rating) in a report issued on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also commented on BPMC. VNET Group reiterated a maintains rating on shares of Blueprint Medicines in a research report on […]

Related Keywords

Blackrock ,United Kingdom General ,United Kingdom ,Cambridge ,Cambridgeshire ,Jeffreyw Albers ,Christina Rossi ,Nicholasb Lydon ,Stifel Nicolaus ,Brian Druker ,Chris Varma ,Metlife Investment Management ,Blueprint Medicines Company Profile ,Blackrock Inc ,Raymond James Associates ,Blueprint Medicines Corp ,Securities Exchange Commission ,Us Bancorp ,Morgan Stanley ,Blueprint Medicines ,Get Rating ,Moderate Buy ,Exchange Commission ,Director Jeffrey ,Life Investment Management ,Alexis Borisy ,Blueprint Medicines Daily ,Nasdaq Bpmc ,Bpmc ,Medical ,Initiated Coverage ,Stocknews Com ,